Drug Delivery Technologies Market Forecast 2016-2026

LONDON, July 22, 2016 /PRNewswire/ --

Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies including 3M, BD and Alkermes

What can be expected from the Drug Delivery Technologies Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.
 
Our 214-page report provides 137 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national drug delivery technologies market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See revenue forecasts for the leading regional and national markets
How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets, including:
• US
• EU5 (Germany, France, UK, Spain and Italy)
• Japan
• China
• India
• Brazil
• Russia
• South Korea
• Mexico
• Rest of the World

To see a report overview please email Sara Peerun on [email protected]

Leading companies and potential for market growth
Visiongain forecasts overall revenue for the Drug Delivery Technologies Market will reach $259.1bn in 2020. We predict high revenue growth over the forecast period driven by big pharma seeking diversification of their top-selling products and a growing demand for more patient-friendly treatments in healthcare.

Our work analyses the key companies in the market. See visiongain's analysis of ten leading companies, including:
• Alkermes
• 3M
• Skyepharma
• Becton Dickinson and Company (BD)
• Antares Pharma
• pSivida
• Applied Pharma Research (APR)
• Ethypharm
• Glycologic
• NanoPass Technologies

A company profile gives you the following information where available:
• Discussion of a company's activities and outlook including regional and national revenue shares
• Historic revenue, analysis and discussion of company performance
• Analysis of major products/services currently available on the market
• Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the drug delivery technologies industry?
Our new report discusses issues and events affecting the drug delivery technologies market. You will find discussions, including qualitative analyses:
• Highly fragmented and competitive market with significant variations in different geographic regions
• Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
• Future opportunities for drug delivery technologies

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Drug Delivery Technologies Market Forecast 2016-2026: Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies including 3M, BD and Alkermesreport helps you:
In summary, our 214-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Drug Delivery Technologies market - discover the industry's prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for three major regional markets - US, EU5 and Rest of the World
• Revenue forecasts to 2026 for the leading national markets - US, Germany, France, UK, Spain, Italy, Japan, China, India, Brazil, Russia, South Korea, Mexico and Rest of the World
• Assessment of leading companies - analysis of services, business operations, revenue (where available) and mergers & acquisitions
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the drug delivery technologies market and leading companies. You will find data, trends and predictions. Please order our report now.

To see a report overview please email Sara Peerun on [email protected]

To request an exec summary of this report please email Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1694/Drug-Delivery-Technologies-Market-Forecast-2016-2026

Companies Mentioned in the Report 

3M

Acorda

Actavis

Adamis

Aleza Pharmaceuticals

Alkermes

Almirall

Alza

Antares Pharma

Applied Pharma Research

Aradigm

Astellas

AstraZeneca

Bayer HealthCare Pharmaceuticals

BD

Biogen

BioGeneration Ventures

Bioject Medical Technologies

Boehringer Ingelheim

Bristol¬Myers Squibb

CareFusion Corporation

Cephalon

Changchun BCHT

Chiesi

Chrono Therapeutics

Cilag

Cima Labs

Clearside

Cosmo Pharmaceuticals

CRISI Medical Systems

CTCBIO

Daiichi

Elan Drug Technologies

Elcam Medical

Eli Lilly

Ethypharm

Ferrer

Ferring

Flamel

Genentech

GlaxoSmithKline

Glycologic

Google

GSK

Haselmeir

Horizon Pharma

ImmusanT

Innovent Biologics

Insmed

Invion

iScience Interventional Corporation

J&J

Janssen

JCR Pharmaceuticals

Kyorin

MannKind

Meda Pharmaceuticals

Medac

Medimetrics

MedImmune

MedSciences Capital

Merck Serono

Mucosis

Mundipharma

Nanopass Technologies

Nektar Therapeutics

Nexvax2

NHTherapeutics

Novartis

Novo Nordisk

NuPathe

NV NOM

Oramed

OwenMumford

Pacira Pharmaceuticals

Pari Pharma

Permatec

Pfizer

PharmaJet

Presspart

ProStrakan

pSivida

Pulmagen

Ranbaxy

Rani Therapeutics

Recro Pharma

Regeneron Pharmaceuticals

Roche

Sandoz

Sanofi-Aventis

Santen

Shionogi

SHL Group

Shreya Life Sciences

Skyepharma

Smoofi

Spark Therapeutics

STADA Arzneimittel

Takeda

Teva

UU Holdings

Vetter Pharma

West Pharmaceuticals

Ypsomed

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain